Literature DB >> 19832701

Lyn-mediated mitochondrial tyrosine phosphorylation is required to preserve mitochondrial integrity in early liver regeneration.

Enrico Gringeri1, Amedeo Carraro, Elena Tibaldi, Francesco E D'Amico, Mario Mancon, Antonio Toninello, Mario A Pagano, Claudia Vio, Umberto Cillo, Anna M Brunati.   

Abstract

Functional alterations in mitochondria such as overproduction of ROS (reactive oxygen species) and overloading of calcium, with subsequent change in the membrane potential, are traditionally regarded as pro-apoptotic conditions. Although such events occur in the early phases of LR (liver regeneration) after two-thirds PH (partial hepatectomy), hepatocytes do not undergo apoptosis but continue to proliferate until the mass of the liver is restored. The aim of the present study was to establish whether tyrosine phosphorylation, an emerging mechanism of regulation of mitochondrial function, participates in the response to liver injury following PH and is involved in contrasting mitochondrial pro-apoptotic signalling. Mitochondrial tyrosine phosphorylation, negligible in the quiescent liver, was detected in the early phases of LR with a trend similar to the events heralding mitochondrial apoptosis and was attributed to the tyrosine kinase Lyn, a member of the Src family. Lyn was shown to accumulate in an active form in the mitochondrial intermembrane space, where it was found to be associated with a multiprotein complex. Our results highlight a role for tyrosine phosphorylation in accompanying, and ultimately counteracting, mitochondrial events otherwise leading to apoptosis, hence conveying information required to preserve the mitochondrial integrity during LR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19832701     DOI: 10.1042/BJ20090902

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  8 in total

1.  Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress.

Authors:  E Fabian; D Reglodi; L Mester; A Szabo; K Szabadfi; A Tamas; G Toth; K Kovacs
Journal:  J Mol Neurosci       Date:  2012-05-29       Impact factor: 3.444

Review 2.  Viral proteins and Src family kinases: Mechanisms of pathogenicity from a "liaison dangereuse".

Authors:  Mario Angelo Pagano; Elena Tibaldi; Giorgio Palù; Anna Maria Brunati
Journal:  World J Virol       Date:  2013-05-12

3.  Regulation of OATP1B1 Function by Tyrosine Kinase-mediated Phosphorylation.

Authors:  Elizabeth R Hayden; Mingqing Chen; Kyle Z Pasquariello; Alice A Gibson; James J Petti; Shichen Shen; Jun Qu; Su Sien Ong; Taosheng Chen; Yan Jin; Muhammad Erfan Uddin; Kevin M Huang; Aviv Paz; Alex Sparreboom; Shuiying Hu; Jason A Sprowl
Journal:  Clin Cancer Res       Date:  2021-03-04       Impact factor: 12.531

Review 4.  Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation.

Authors:  Sangbin Lim; Kelly R Smith; Ssang-Taek Steve Lim; Rong Tian; Jianrong Lu; Ming Tan
Journal:  Cell Biosci       Date:  2016-04-14       Impact factor: 7.133

5.  Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells.

Authors:  Elena Tibaldi; Mario Angelo Pagano; Federica Frezzato; Valentina Trimarco; Monica Facco; Giuseppe Zagotto; Giovanni Ribaudo; Valeria Pavan; Luciana Bordin; Andrea Visentin; Francesca Zonta; Gianpietro Semenzato; Anna Maria Brunati; Livio Trentin
Journal:  Haematologica       Date:  2017-06-15       Impact factor: 9.941

6.  BIRC6 mediates imatinib resistance independently of Mcl-1.

Authors:  Denis O Okumu; Michael P East; Merlin Levine; Laura E Herring; Raymond Zhang; Thomas S K Gilbert; David W Litchfield; Yanping Zhang; Lee M Graves
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

Review 7.  Mitochondrial Kinases and the Role of Mitochondrial Protein Phosphorylation in Health and Disease.

Authors:  Veronika Kotrasová; Barbora Keresztesová; Gabriela Ondrovičová; Jacob A Bauer; Henrieta Havalová; Vladimír Pevala; Eva Kutejová; Nina Kunová
Journal:  Life (Basel)       Date:  2021-01-23

8.  Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation.

Authors:  Yue Jin; Qingsong Cai; Anitha K Shenoy; Sangbin Lim; Ying Zhang; Steve Charles; Miriam Tarrash; Xueqi Fu; Sushama Kamarajugadda; Jose G Trevino; Ming Tan; Jianrong Lu
Journal:  Oncotarget       Date:  2016-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.